Explore the challenges of ADC characterization, key techniques, and the benefits of partnering with a CDMO for effective ...

After hours: September 20 at 7:53 PM EDT Loading Chart for DNA ...

Developing effective inhibitors of the DNA repair enzyme tyrosyl-DNA phosphodiesterase ... conformation that is maintained even after conjugation onto carbon nanotubes and confers increased ...

In an interview with Targeted Oncology, Mark R. Litzow, MD, discussed the incorporation of Immunotherapy into upfront acute ...

The Plague May Have Caused the Downfall of the Stone Age Farmers July 10, 2024 — Ancient DNA from bones and teeth hints at a role of the plague in Stone Age population collapse. Contrary to ...

DNA replication is the biological process by which an exact copy of a deoxyribonucleic acid (DNA) molecule is created and it is the basis for biological inheritance. Each of the two strands of the ...

K Heran Darwin is at New York University Grossman School of Medicine and a regular columnist for EMBO reports.

Sep. 18, 2024 — Researchers found that a medicine called ferric carboxymaltose given in drip through the vein works faster and better than an iron tablet taken by mouth for the treatment of ...

Raludotatug Deruxtecan, a CDH6-Targeting Antibody–Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models DXd ADC is a novel ADC therapeutic ...

Vobra duo (MGC018) is an investigational B7 homolog 3 (B7-H3; CD276)-targeting antibody-drug conjugate (ADC) with a duocarmycin-based DNA-alkylating payload. B7-H3 is highly expressed in multiple ...